The binding of HIV-1 gp41 membrane proximal domain to its mucosal receptor, galactosyl ceramide, is structure-dependent

Cell Calcium

Volumn 43, Issue 1, 2008, Pages 73-82

  Yu, Huifeng ^a,b   Alfsen, Annette ^a,b   Tudor, Daniela ^a,b   Bomsel, Morgane ^a,b  

^a INSTITUT COCHIN   (France)

^b INSERM   (France)

Author keywords

Calcium; Galactosyl ceramide; Glycosphingolipid; HIV 1 gp41; Lectin; Mucosa

Indexed keywords

CALCIUM; EPITOPE; GALACTOSE; GALACTOSYLCERAMIDE; GLYCOPROTEIN GP 41; NEUTRALIZING ANTIBODY; VIRUS RECEPTOR;

ANTIBODY PRODUCTION; ARTICLE; BINDING AFFINITY; BINDING SITE; CALCIUM BINDING; CALCIUM CELL LEVEL; CIRCULAR DICHROISM; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; HUMAN IMMUNODEFICIENCY VIRUS 1; MUCOSA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN SECONDARY STRUCTURE; PROTEIN STRUCTURE; PROTEIN TERTIARY STRUCTURE; STRUCTURE ANALYSIS;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 38049031709     PISSN: 01434160     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ceca.2007.04.011     Document Type: Article

References (61)

1. Meng G., Wei X., Wu X., Sellers M.T., Decker J.M., Moldoveanu Z., Orenstein J.M., Graham M.F., Kappes J.C., Mestecky J., Shaw G.M., and Smith P.D. Primary intestinal epithelial cells selectively transfer R5 HIV-1 to CCR5+ cells. Nat. Med. 8 (2002) 150-156
2. Phillips D.M. The role of cell-to-cell transmission in HIV infection. Aids 8 (1994) 719-731
3. Hu Q., Frank I., Williams V., Santos J.J., Watts P., Griffin G.E., Moore J.P., Pope M., and Shattock R.J. Blockade of attachment and fusion receptors inhibits HIV-1 infection of human cervical tissue. J. Exp. Med. 199 (2004) 1065-1075
4. Miller C.J., and Shattock R.J. Target cells in vaginal HIV transmission. Microbes Infect. 5 (2003) 59-67
5. Frank I., and Pope M. The enigma of dendritic cell-immunodeficiency virus interplay. Curr. Mol. Med. 2 (2002) 229-248
6. Bomsel M. Transcytosis of infectious human immunodeficiency virus across a tight human epithelial cell line barrier. Nat. Med. 3 (1997) 42-47
7. Bomsel M., Heyman M., Hocini H., Lagaye S., Belec L., Dupont C., and Desgranges C. Intracellular neutralization of HIV transcytosis across tight epithelial barriers by anti-HIV envelope protein dIgA or IgM. Immunity 9 (1998) 277-287
8. Simons K., and van Meer G. Lipid sorting in epithelial cells. Biochemistry 27 (1988) 6197-6202
9. Fantini J., Cook D.G., Nathanson N., Spitalnik S.L., and Gonzalez-Scarano F. Infection of colonic epithelial cell lines by type 1 human immunodeficiency virus is associated with cell surface expression of galactosylceramide, a potential alternative gp120 receptor. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 2700-2704
10. Yahi N., Spitalnik S.L., Stefano K.A., De Micco P., Gonzalez-Scarano F., and Fantini J. Interferon-gamma decreases cell surface expression of galactosyl ceramide, the receptor for HIV-1 GP120 on human colonic epithelial cells. Virology 204 (1994) 550-557
11. Yahi N., Sabatier J.M., Nickel P., Mabrouk K., Gonzalez-Scarano F., and Fantini J. Suramin inhibits binding of the V3 region of HIV-1 envelope glycoprotein gp120 to galactosylceramide, the receptor for HIV-1 gp120 on human colon epithelial cells. J. Biol. Chem. 269 (1994) 24349-24353
12. Long D., Berson J.F., Cook D.G., and Doms R.W. Characterization of human immunodeficiency virus type 1 gp120 binding to liposomes containing galactosylceramide. J. Virol. 68 (1994) 5890-5898
13. Alfsen A., Iniguez P., Bouguyon E., and Bomsel M. Secretory IgA specific for a conserved epitope on gp41 envelope glycoprotein inhibits epithelial transcytosis of HIV-1. J. Immunol. 166 (2001) 6257-6265
14. Alfsen A., and Bomsel M. HIV-1 gp41 envelope residues 650-685 exposed on native virus act as a lectin to bind epithelial cell galactosyl ceramide. J. Biol. Chem. 277 (2002) 25649-25659
15. Fantini J., Maresca M., Hammache D., Yahi N., and Delezay O. Glycosphingolipid (GSL) microdomains as attachment platforms for host pathogens and their toxins on intestinal epithelial cells: activation of signal transduction pathways and perturbations of intestinal absorption and secretion. Glycoconj. J. 17 (2000) 173-179
16. Rietveld A., and Simons K. The differential miscibility of lipids as the basis for the formation of functional membrane rafts. Biochim. Biophys. Acta 10 (1998) 467-479
17. Brown D.A., and London E. Functions of lipid rafts in biological membranes. Annu. Rev. Cell Dev. Biol. 14 (1998) 111-136
18. Hansen G.H., Niels-Christiansen L.L., Immerdal L., Hunziker W., Kenny A.J., and Danielsen E.M. Transcytosis of immunoglobulin A in the mouse enterocyte occurs through glycolipid raft- and rab17-containing compartments. Gastroenterology 116 (1999) 610-622
19. Verkade P., Harder T., Lafont F., and Simons K. Induction of caveolae in the apical plasma membrane of Madin-Darby canine kidney cells. J. Cell Biol. 148 (2000) 727-739
20. Magerus-Chatinet A., Yu H., Garcia S., Ducloux E., Terris B., and Bomsel M. Galactosyl ceramide expressed on dendritic cells can mediate HIV-1 transfer from monocyte derived dendritic cells to autologous T cells. Virology 16 (2007) 16
21. Eckert D.M., and Kim P.S. Mechanisms of viral membrane fusion and its inhibition. Annu Rev. Biochem. 70 (2001) 777-810
22. Weissenhorn W., Dessen A., Calder L.J., Harrison S.C., Skehel J.J., and Wiley D.C. Structural basis for membrane fusion by enveloped viruses. Mol. Membr. Biol. 16 (1999) 3-9
23. Zanetti G., Briggs J.A., Grunewald K., Sattentau Q.J., and Fuller S.D. Cryo-electron tomographic structure of an immunodeficiency virus envelope complex in situ. PLoS Pathog. 2 (2006)
24. Zhu P., Liu J., Bess Jr. J., Chertova E., Lifson J.D., Grise H., Ofek G.A., Taylor K.A., and Roux K.H. Distribution and three-dimensional structure of AIDS virus envelope spikes. Nature 441 (2006) 847-852
25. Mascola J.R., Stiegler G., VanCott T.C., Katinger H., Carpenter C.B., Hanson C.E., Beary H., Hayes D., Frankel S.S., Birx D.L., and Lewis M.G. Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies. Nat. Med. 6 (2000) 207-210
26. Kozlowski P.A., and Neutra M.R. The role of mucosal immunity in prevention of HIV transmission. Curr. Mol. Med. 3 (2003) 217-228
27. Wang S.W., Bertley F.M., Kozlowski P.A., Herrmann L., Manson K., Mazzara G., Piatak M., Johnson R.P., Carville A., Mansfield K., and Aldovini A. An SHIV DNA/MVA rectal vaccination in macaques provides systemic and mucosal virus-specific responses and protection against AIDS. AIDS Res. Hum. Retroviruses 20 (2004) 846-859
28. Veazey R.S., Klasse P.J., Schader S.M., Hu Q., Ketas T.J., Lu M., Marx P.A., Dufour J., Colonno R.J., Shattock R.J., Springer M.S., and Moore J.P. Protection of macaques from vaginal SHIV challenge by vaginally delivered inhibitors of virus-cell fusion. Nature 438 (2005) 99-102
29. Kliger Y., and Shai Y. Inhibition of HIV-1 entry before gp41 folds into its fusion-active conformation. J. Mol. Biol. 295 (2000) 163-168
30. Zwick M.B., Jensen R., Church S., Wang M., Stiegler G., Kunert R., Katinger H., and Burton D.R. Anti-human immunodeficiency virus type 1 (HIV-1) antibodies 2F5 and 4E10 require surprisingly few crucial residues in the membrane-proximal external region of glycoprotein gp41 to neutralize HIV-1. J. Virol. 79 (2005) 1252-1261
31. Mo H., Konstantinidis A.K., Stewart K.D., Dekhtyar T., Ng T., Swift K., Matayoshi E.D., Kati W., Kohlbrenner W., and Molla A. Conserved residues in the coiled-coil pocket of human immunodeficiency virus type 1 gp41 are essential for viral replication and interhelical interaction. Virology 329 (2004) 319-327
32. Matoba N., Magerus A., Geyer B.C., Zhang Y., Muralidharan M., Alfsen A., Arntzen C.J., Bomsel M., and Mor T.S. A mucosally targeted subunit vaccine candidate eliciting HIV-1 transcytosis-blocking Abs. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 13584-13589
33. Matoba N., Geyer B.C., Kilbourne J., Alfsen A., Bomsel M., and Mor T.S. Humoral immune responses by prime-boost heterologous route immunizations with CTB-MPR(649-684), a mucosal subunit HIV/AIDS vaccine candidate. Vaccine 24 (2006) 5047-5055
34. Stiegler G., Kunert R., Purtscher M., Wolbank S., Voglauer R., Steindl F., and Katinger H. A potent cross-clade neutralizing human monoclonal antibody against a novel epitope on gp41 of human immunodeficiency virus type 1. AIDS Res. Hum. Retroviruses 17 (2001) 1757-1765
35. Zwick M.B., Labrijn A.F., Wang M., Spenlehauer C., Saphire E.O., Binley J.M., Moore J.P., Stiegler G., Katinger H., Burton D.R., and Parren P.W. Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41. J. Virol. 75 (2001) 10892-10905
36. Zwick M.B., Wang M., Poignard P., Stiegler G., Katinger H., Burton D.R., and Parren P.W. Neutralization synergy of human immunodeficiency virus type 1 primary isolates by cocktails of broadly neutralizing antibodies. J. Virol. 75 (2001) 12198-12208
37. Munoz-Barroso I., Salzwedel K., Hunter E., and Blumenthal R. Role of the membrane-proximal domain in the initial stages of human immunodeficiency virus type 1 envelope glycoprotein-mediated membrane fusion. J. Virol. 73 (1999) 6089-6092
38. Suarez T., Gallaher W.R., Agirre A., Goni F.M., and Nieva J.L. Membrane interface-interacting sequences within the ectodomain of the human immunodeficiency virus type 1 envelope glycoprotein: putative role during viral fusion. J. Virol. 74 (2000) 8038-8047
39. Salzwedel K., West J.T., and Hunter E. A conserved tryptophan-rich motif in the membrane-proximal region of the human immunodeficiency virus type 1 gp41 ectodomain is important for Env-mediated fusion and virus infectivity. J. Virol. 73 (1999) 2469-2480
40. Saez-Cirion A., Nir S., Lorizate M., Agirre A., Cruz A., Perez-Gil J., and Nieva J.L. Sphingomyelin and cholesterol promote HIV-1 gp41 pretransmembrane sequence surface aggregation and membrane restructuring. J. Biol. Chem. 277 (2002) 21776-21785
41. Sanchez-Martinez S., Lorizate M., Katinger H., Kunert R., and Nieva J.L. Membrane association and epitope recognition by HIV-1 neutralizing anti-gp41 2F5 and 4E10 antibodies. AIDS Res. Hum. Retroviruses 22 (2006) 998-1006
42. Shnaper S., Sackett K., Gallo S.A., Blumenthal R., and Shai Y. The C- and the N-terminal regions of glycoprotein 41 ectodomain fuse membranes enriched and not enriched with cholesterol, respectively. J. Biol. Chem. 279 (2004) 18526-18534
43. Aloia R.C., Tian H., and Jensen F.C. Lipid composition and fluidity of the human immunodeficiency virus envelope and host cell plasma membranes. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 5181-5185
44. Ebenbichler C.F., Stoiber H., Schneider R., Patsch J.R., and Dierich M.P. The human immunodeficiency virus type 1 transmembrane gp41 protein is a calcium-binding protein and interacts with the putative second-receptor molecules in a calcium-dependent manner. J. Virol. 70 (1996) 1723-1728
45. Rini J.M. Lectin structure. Annu. Rev. Biophys. Biomol. Struct. 24 (1995) 551-577
46. Drickamer K. Engineering galactose-binding activity into a C-type mannose-binding protein. Nature 360 (1992) 183-186
47. McLaughlin S., Smith S.O., Hayman M.J., and Murray D. An electrostatic engine model for autoinhibition and activation of the epidermal growth factor receptor (EGFR/ErbB) family. J. Gen. Physiol. 126 (2005) 41-53
48. Bowen M., and Brunger A.T. Conformation of the synaptobrevin transmembrane domain. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 8378-8383
49. Callahan M.K., Popernack P.M., Tsutsui S., Truong L., Schlegel R.A., and Henderson A.J. Phosphatidylserine on HIV envelope is a cofactor for infection of monocytic cells. J. Immunol. 170 (2003) 4840-4845
50. Anzinger J.J., Mezo I., Ji X., Gabali A.M., Thomas L.L., and Spear G.T. HIV infection of mononuclear cells is calcium-dependent. Virus Res. 122 (2006) 183-188
51. Chen R.F., Edelhoch H., and Steiner R.F. Fluorecence of proteins. In: Leach S.J. (Ed). Physical principle and techniques of protein chemistry (1969), Academic press, NewYork, USA 171-244
52. Linse S., Helmersson A., and Forsen S. Calcium binding to calmodulin and its globular domains. J. Biol. Chem. 266 (1991) 8050-8054
53. 2+ in calbindin D9k. Biochemistry 30 (1991) 154-162
54. 2+-binding constants of proteins and presentation of the CaLigator software. Anal. Biochem. 305 (2002) 195-205
55. Whitmore L., and Wallace B.A. DICHROWEB, an online server for protein secondary structure analyses from circular dichroism spectroscopic data. Nucleic Acids Res. 32 (2004) W668-W673
56. Lobley A., Whitmore L., and Wallace B.A. DICHROWEB: an interactive website for the analysis of protein secondary structure from circular dichroism spectra. Bioinformatics 18 (2002) 211-212
57. Coutant J., Yu H., Alfsen A., Bomsel M., Toma F., and Curmi P. Structural flexibility of HIV gp41-membrane proximal region P1 peptide at physiological pH. XXIIend international conference on magnetic resonance in Biological System (ICMRBS). Gottingen, Germany, August (2006)
58. Biron Z., Khare S., Quadt S.R., Hayek Y., Naider F., and Anglister J. The 2F5 epitope is helical in the HIV-1 entry inhibitor T-20. Biochemistry 44 (2005) 13602-13611
59. Alfsen A., Yu H., Magerus-Chatinet A., Schmitt A., and Bomsel M. HIV-1-infected blood mononuclear cells form an integrin- and agrin-dependent viral synapse to induce efficient HIV-1 transcytosis across epithelial cell monolayer. Mol. Biol. Cell 16 (2005) 4267-4279
60. Schibli D.J., Montelaro R.C., and Vogel H.J. The membrane-proximal tryptophan-rich region of the HIV glycoprotein, gp41, forms a well-defined helix in dodecylphosphocholine micelles. Biochemistry 40 (2001) 9570-9578
61. Linse S., Brodin P., Johansson C., Thulin E., Grundstrom T., and Forsen S. The role of protein surface charges in ion binding. Nature 335 (1988) 651-652